Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2007;38:748-752
doi: 10.1161/01.STR.0000253500.32979.d1
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, B.-Q.
Right arrow Articles by Lo, E. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, B.-Q.
Right arrow Articles by Lo, E. H.
Related Collections
Right arrow Animal models of human disease
Right arrow Acute Cerebral Hemorrhage
Right arrow Acute Cerebral Infarction

(Stroke. 2007;38:748.)
© 2007 American Heart Association, Inc.


Intracerebral Hemorrhage: Introduction

Neurovascular Proteases in Brain Injury, Hemorrhage and Remodeling After Stroke

Bing-Qiao Zhao, MD; Emiri Tejima, MD Eng H. Lo, PhD

From the Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital, and Program in Neuroscience, Harvard Medical School, Boston, Mass.

Correspondence to Eng H. Lo, Neuroprotection Research Laboratory, Massachusetts General Hospital, East 149-2401, Charlestown, MA 02129. E-mail Lo{at}helix.mgh.harvard.edu

Abstract

Matrix metalloproteinases (MMPs) mediate tissue injury during acute stroke. Clinical data show that elevated MMPs in plasma of stroke patients may correlate with outcomes, suggesting its use as a biomarker. MMP-9 signal has also been detected in clinical stroke brain tissue samples. Because tissue plasminogen activator can upregulate MMPs via lipoprotein receptor signaling, these neurovascular proteolytic events may underlie some of the complications of edema and hemorrhage that plague thrombolytic therapy. However, in contrast to its deleterious actions in acute stroke, MMPs and other neurovascular proteases may play beneficial roles during stroke recovery. MMPs are increased in the subventricular zone weeks after focal stroke, and inhibition of MMPs suppress neurogenic migration from subventricular zone into damaged tissue. In peri-infarct cortex, MMPs may mediate neurovascular remodeling. Delayed inhibition of MMPs decrease markers of remodeling, and these phenomena may be related to reductions in bioavailable growth factors. Acute versus chronic protease profiles within the neurovascular unit are likely to underlie critical responses to stroke, therapy, and recovery.


Key Words: matrix proteins • neuroregeneration • pathology ischemia




This article has been cited by other articles:


Home page
StrokeHome page
K.-P. Park, A. Rosell, C. Foerch, C. Xing, W. J. Kim, S. Lee, G. Opdenakker, K. L. Furie, and E. H. Lo
Plasma and Brain Matrix Metalloproteinase-9 After Acute Focal Cerebral Ischemia in Rats
Stroke, August 1, 2009; 40(8): 2836 - 2842.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. W. McColl, N. J. Rothwell, and S. M. Allan
Systemic Inflammation Alters the Kinetics of Cerebrovascular Tight Junction Disruption after Experimental Stroke in Mice
J. Neurosci., September 17, 2008; 28(38): 9451 - 9462.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. E. Benarroch
Tissue plasminogen activator: Beyond thrombolysis
Neurology, August 21, 2007; 69(8): 799 - 802.
[Full Text] [PDF]